Cytomics Limited is a development stage startup based in Hong Kong offering proprietary computational biology solutions that provide new types of SINGLE CELL TYPE biomarkers for applications in disease diagnosis and prognosis.
Cytomics HK
《聯合邁進》第二十七期
www.uc.cuhk.edu.hk/publication/mar-2023-vol-27/
多謝聯合書院的訪問.
Cytomics HK
感謝校友編輯Sammy Poon的訪問和報導。
www.alumni.cuhk.edu.hk/.../pdf/CUAM_202212_12-13.pdf
Cytomics HK
Our booth was visited by Mr Daren Tang, Director General of World Intellectual Property Organisation (WIPO) during a VIP Tour in HKTDC E-Day 2022.
Thank you for your support !
Cytomics HK
Merry Christmas🎄
Cytomics HK
We have a product readily used as companion diagnostics for cancer vaccine to identify patients who are likely to have favorable response to vaccine treatment. It spins out from our earlier work in development of a rapid response biomarker for COVID vaccination. cytomics.com.cn/en/new-patent/2/ New Generation of blood test for vaccination
Experimental cancer vaccine shows promise in animal studies
NIH researchers find IV administration improves tumor-fighting action